Semarion, a University of Cambridge spinout company, has closed a £2.1 million seed funding round.  Emerging from the prestigious Cavendish Laboratory, Semarion combines materials engineering and cell biology to tackle unmet drug screening needs. The investment round was led by Parkwalk Advisors, with the University of Cambridge Seed Funds, Martlet Capital and angel investors also … Continue reading Cambridge University spinout Semarion raises £2.1m